Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimotuzumab plus Irinotecan in Metastatic Colorectal Cancer
NCT05278728Phase 2Completed
- Start
- Jul 2009
- Primary completion
- Aug 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nimotuzumab in colorectal cancer (CRC). Started Jul 2009; status: completed.
02
Drugs
nimotuzumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05278728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05278728.